0001104659-26-020655
SEC filingRevenue surged 48% YoY to $251.7M, driven by DDS segment growth, with gross margin improving to 40%.
Innodata Inc. (Nasdaq: INOD) describes itself as a global data engineering and AI systems services company that supports the development, training, post-training, evaluation, and deployment of advanced artificial intelligence systems. Founded more than 35 years ago, the company partners with leading technology companies, frontier AI laboratories, and enterprises to enable AI systems that perform reliably and operate safely. The company's mission is to enable responsible advancement of AI by providing data, evaluation frameworks, and human expertise.
The Company's operations are classified into three reporting segments: Digital Data Solutions (DDS), Synodex, and Agility. DDS provides training and post-training data development, alignment and preference optimization, capabilities and safety evaluation, and AI enablement. Synodex transforms medical records into structured digital data for insurance and healthcare workflows. Agility provides media intelligence and public relations workflow software enhanced with AI-driven monitoring, analytics, and content capabilities. Revenue share by segment is not explicitly disclosed, but one DDS customer accounted for 58% of total revenues in fiscal 2025.
Key named platforms include Synodex, which structures medical records, and Agility PR Solutions, which delivers media intelligence. The company also operates Innodata Labs (long-term innovation research), Technology Practices (applied research and scalable solutions), and platform engineering teams, but these are not standalone products. The platforms emphasize modularity, interoperability, and model-agnostic design.
Innodata markets primarily through a direct sales model supported by professional staff, senior management, and dedicated sales personnel in the U.S., Canada, the U.K., and Europe. Strategic partnerships and channel relationships are selectively developed. Customers include five of the "Magnificent Seven" technology companies and leading AI research labs. For fiscal 2025, one DDS customer represented 58% of total revenues (48% in 2024). International revenue accounted for 16% in 2025 and 21% in 2024. Customer agreements are generally terminable on 30 to 90 days' notice.
The market is highly competitive. Named competitors include specialized AI data and evaluation providers such as Appen, CloudFactory, Surge AI, Invisible Technologies, Turing, Mercor, Define.a, TELUS Digital, and Scale AI, as well as broader consulting and outsourcing firms like Accenture, Cognizant, EXLService, Genpact, Infosys, PwC, QuantumBlack, and Tata Consultancy Services. Innodata differentiates on service quality, technical depth, scalability, information security, and the ability to support multiple AI lifecycle stages.
The growth strategy comprises four pillars: (1) expanding relationships with existing customers as their AI initiatives mature; (2) driving new customer acquisition, including a new Federal Practice for U.S. government agencies; (3) developing new capabilities and product innovation, especially in agentic trust and safety; and (4) continuing innovation with a long-term perspective, funding investments primarily through internal resources. The company also pursues charter customer relationships and external advisory relationships.
As of December 31, 2025, Innodata employed 10,107 employees, 10,020 of whom are full-time. Many hold advanced degrees in specialized fields. Additionally, the company's global delivery platform engages 12,200 professionals across more than 70 countries, supporting multilingual and culturally informed operations. No employees are represented by a labor union.
For the year ended December 31, 2025, Innodata reported total revenues of $251.7 million, a 48% increase from $170.5 million in 2024. Gross profit rose to $99.5 million from $67.1 million, with gross margin improving to 40% from 39%, driven by higher revenues in the DDS and Agility segments. Operating income increased 64% to $39.9 million, and net income grew 12% to $32.2 million. Basic earnings per share rose to $1.01 from $0.98. The revenue growth was primarily fueled by a 57% surge in the DDS segment, partially offset by an 8% decline in Synodex. Direct operating costs grew 47% to $152.2 million, while selling and administrative expenses increased 40% to $59.6 million, both reflecting investments in workforce and capabilities.
The DDS segment, the largest contributor, generated $220.9 million in revenue, up 57% year-over-year. Its gross margin improved to 39% from 37%, benefiting from operating leverage. A single customer accounted for 58% of total company revenues. Synodex revenue fell 8% to $7.3 million due to a contract termination, with gross margin contracting to 18% from 27%. Agility revenue grew 9% to $23.5 million, but gross margin declined to 54% from 56% due to higher direct costs. Non-GAAP adjusted gross margin for DDS improved to 41% from 39%, while Synodex and Agility saw declines. Consolidated adjusted EBITDA increased 68% to $57.9 million, with DDS contributing $53.1 million.
Management expects capital expenditures of approximately $12.1 million in 2026 for technology, platform development, and infrastructure. The company continues to invest in sales, marketing, and R&D to capture AI-driven demand. Despite the favorable revenue trajectory, risks include customer concentration, foreign exchange exposure, and inflationary wage pressures. The company maintains a strong liquidity position with $82.2 million in cash and equivalents, and expects existing cash and operating cash flows to meet needs for at least 12 months.
From the Notes, total assets reached $168.6M at December 31, 2025, up from $113.4M a year earlier. Accounts receivable net grew to $46.5M (from $28.0M), reflecting revenue growth. Intangible assets (net) were $14.0M, with $13.6M in capitalized software. The company had $7.5M in deferred revenue, slightly down from $8.0M. Long-term obligations totaled $7.6M, primarily pension liabilities. Deferred tax assets net were $3.3M. No cash or marketable securities are disclosed in the notes.
Purchase commitments include a Microsoft license agreement with annual payments of $0.4M through February 2026. Operating lease commitments total $5.2M undiscounted, with $1.6M due within one year and $2.7M in years 1-3. Contingent liabilities include a Philippine labor judgment of $5.6M plus interest, but no accrual is recorded as the company is contesting it.
The company did not repurchase any shares in 2025; $0.2M remains under the 2019 buyback authorization. No dividends were declared. Long-term obligations increased by $0.9M, primarily from higher pension liabilities, while Microsoft license debt decreased. The revolving credit facility ($30M maximum) was undrawn and compliant with covenants. No capex figure appears in the notes, but capitalized software additions are reflected in the intangible asset increase.
The DDS segment generated 87.7% of total revenue ($220.8M), with 56.5% YoY growth and an operating margin of 17.8%. Synodex revenue declined 6.9% to $7.3M, with an operating margin of 8.5%. Agility revenue grew 9.4% to $23.5M but posted a slight operating loss (-$0.2M). Geographically, 84% of revenue came from the U.S., with Canada, UK, Netherlands, and other European countries comprising the balance. One DDS customer accounted for 58% of consolidated revenue, indicating high concentration.
Innodata's 10-K reveals extreme reliance on a single DDS segment customer, which generated 58% and 48% of total revenues in 2025 and 2024, respectively. No other customer contributed over 10%. The loss of this customer, variation in work volume, or price concessions would materially harm results. Contracts are generally terminable on 30–90 days' notice, with no obligations for future purchases.
The company faces high competition from larger firms and new entrants with lean cost structures. Rapid technological change in AI and IT requires continuous innovation; failure could render services obsolete. Dependence on third-party software, data centers, and content providers (Agility segment) introduces disruption risks. Talent attrition is a concern, especially given reliance on key employees like the CEO and geographically dispersed operations (Philippines, India, Sri Lanka, Canada, etc.).
Operations in the Philippines, India, Sri Lanka, and Israel expose Innodata to political unrest, terrorism, natural calamities, currency fluctuations, and tax uncertainties. High inflation in Asian countries exerts wage pressure, while anti-outsourcing legislation (e.g., HIRE Act) could penalize offshore service use. Visa restrictions may hinder staffing.
A variable-rate revolving credit facility (based on SOFR) and restrictive covenants (e.g., fixed charge coverage ratio ≥1.10x) limit financial flexibility. One customer accounts for 63% of accounts receivable ($29.2M), heightening credit risk. Quarterly revenue fluctuations are typical due to project-based work, and high fixed costs can amplify margin volatility.
Outstanding litigation includes a Philippine labor judgment (~$5.6M plus interest) and a securities class action alleging misstatements about AI capabilities. The company is defending both. Evolving AI regulations, data privacy laws, and corporate governance requirements could increase compliance costs. Past disclosure control deficiencies, though currently resolved, pose recurrence risk.
Cybersecurity is managed under ISO 27001:2022 with a CISO; no material incidents were reported. However, reliance on distributed IT systems and third-party vendors creates vulnerability to attacks, data breaches, and service disruptions, which could lead to financial loss and reputational damage.
The provided document excerpt does not contain actual cash flow statement figures. It only references that the consolidated statements of cash flows are included in Item 8 and lists the pages. No numeric data was extracted.